Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ruud T M, van der Hoeven"'
Autor:
Joanna E, Klopotowska, Paul F M, Kuks, Peter C, Wierenga, Clementine C M, Stuijt, Lambertus, Arisz, Marcel G W, Dijkgraaf, Nicolette, de Keizer, Susanne M, Smorenburg, Sophia E, de Rooij, Ruud T M, van der Hoeven
Publikováno v:
BMC geriatrics, 22(1):505. BioMed Central
Background The effectiveness of interventions to improve medication safety in older inpatients is unclear, given a paucity of properly designed intervention studies applying clinically relevant endpoints such as hospital-acquired preventable Adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1bf6f398cd6203587a11a33e51079a
https://doi.org/10.1186/s12877-022-03118-z
https://doi.org/10.1186/s12877-022-03118-z
Autor:
Matthijs L, Becker, Fatih, Baypinar, Marieke, Pereboom, Soufiane, Lilih, Ruud T M, van der Hoeven, Thijs J, Giezen, Hylke Jan, Kingma
Publikováno v:
International journal of clinical pharmacy. 43(1)
Background In advanced clinical decision support systems, patient characteristics and laboratory values are included in the algorithms that generate alerts. These alerts have a higher specificity than basic medication surveillance alerts. The alerts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1fb1276514afebb428bacc00f0f5240
https://pubmed.ncbi.nlm.nih.gov/32996074
https://pubmed.ncbi.nlm.nih.gov/32996074
Autor:
Marieke, Pereboom, Matthijs L, Becker, Mostapha, Amenchar, Sjoerd L, Verweij, Ruud T M, van der Hoeven, Inge J, Mulder
Publikováno v:
International journal of pharmaceutical compounding. 19(1)
Intravitreal bevacizumab is frequently used off-label for the treatment of neovascular age-related macular degeneration, but there are concerns about the safety of intravitreal administered bevacizumab. It is suggested that repackaging bevacizumab in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32ee88fd35c9e4458c41636041914348
https://pubmed.ncbi.nlm.nih.gov/25902630
https://pubmed.ncbi.nlm.nih.gov/25902630
Autor:
Joanna E, Klopotowska, Peter C, Wierenga, Sophia E, de Rooij, Clementine C, Stuijt, Lambertus, Arisz, Paul F, Kuks, Marcel G, Dijkgraaf, Loraine, Lie-A-Huen, Susanne M, Smorenburg, Ruud T M, van der Hoeven
Publikováno v:
BMC Health Services Research, Vol 11, Iss 1, p 124 (2011)
BMC Health Services Research
BMC health services research, 1(1), 11-124. BioMed Central
BMC Health Services Research, 1(1), 11-124. BioMed Central
BMC Health Services Research
BMC health services research, 1(1), 11-124. BioMed Central
BMC Health Services Research, 1(1), 11-124. BioMed Central
Background The potential of clinical interventions, aiming at reduction of preventable Adverse Drug Events (preventable ADEs) during hospital stay, have been studied extensively. Clinical Pharmacy is a well-established and effective service, usually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee4c6c7cb1faee3060143a60c57a7aa
http://www.biomedcentral.com/1472-6963/11/124
http://www.biomedcentral.com/1472-6963/11/124